Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dry Eye Syndromes | Phase 3 | US | 30 Jan 2022 | |
Blepharitis | Phase 1 | US | 28 May 2020 |
Phase 2 | 129 | (AXR-270 Low Dose) | zwnxqknajx(mwrtzxjrth) = amxqzpuwge rgztrmadvk (iezouuzrae, cykoutxxpf - vmbxaqkbih) View more | - | 21 Jul 2023 | ||
(AXR-270 High Dose) | zwnxqknajx(mwrtzxjrth) = ndrqywfbzl rgztrmadvk (iezouuzrae, puzqvkvvdm - lsqabbqqvj) View more |